Align Technology | ALGN - Current Assets


Align Technology reported $2.73B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
3M USD 16.71B 2.6B Sep/2026
Align Technology USD 2.73B 63.03M Sep/2026
Becton, Dickinson and Co. USD 8.32B 178M Sep/2026
Bruker USD 2.16B 67.9M Sep/2026
Cardinal Health USD 40.99B 2.24B Sep/2026
Charles River Laboratories USD 1.54B 5.92M Sep/2026
Cooper Companies USD 2.28B 18.3M Jun/2026
CVS Health USD 79.39B 4.05B Sep/2026
Danaher USD 14.79B 1.41B Sep/2026
Dentsply International USD 1.98B 50M Sep/2026
Dexcom USD 3.92B 170.6M Sep/2026
Henry Schein USD 4.78B 176M Sep/2026
Idexx Laboratories USD 1.5B 9.48M Sep/2026
Insulet USD 2.04B 192.4M Sep/2026
Integra LifeSciences USD 1.19B 1.54M Sep/2026
IQVIA Holdings USD 6.45B 225M Sep/2026
McKesson USD 66.68B 3.85B Sep/2026
Mettler Toledo International USD 1.38B 28.79M Sep/2026
Revvity USD 1.86B 436.33M Sep/2026
Solventum Corp USD 3.69B 49M Sep/2026
Stryker USD 14.18B 235M Sep/2026
Teleflex USD 1.84B 31.2M Sep/2026
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
Veeva Systems USD 7.95B 117.03M Jun/2026
Waters USD 3.9B 186M Jun/2026
Zimmer Biomet Holdings USD 5.13B 32.3M Sep/2026
Zoetis USD 6.29B 63M Sep/2026